retatrutide clinical trial saudi arabia A new from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes ESC 2024: Retatrutide improves lipid

Today, a new technology Renuvion skin tightening offers a scarless alternative for patients with mild to moderate skin laxity, especially after GLP-1 weight loss

Berberine, dietary fibre supplements (such as psyllium and glucomannan), and omega-3 fatty acids have preliminary evidence for modest effects on GLP-1 levels

NICE guideline NG28 ( Type 2 diabetes in adults: management ) and current NICE obesity guidance emphasise the importance of regular monitoring and a multidisciplinary approach to care

Prioritizing nutrient-dense foods and moving your body more are important to improving your long-term health when taking a GLP-1